FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Disclosed is a method of producing a unified intestinal medium for culturing intestinal bacteria for medical and agricultural microbiology, comprising adding to 1 l of distilled water 9.0 g of pectin, 9.0 g of xylan, 9.0 g of arabinogalactan, 9.0 g of amylopectin, 43.7 g of casein, 74.6 g of starch, 31.5 g of Tween 80, 43.7 g of bacto peptone, 0.7 g of sterile bovine bile, 4.7 g of K2HPO4x3H2O, 8.4 g of NaCl, 0.009 g of FeSO4x7H2O, 0.7 g of MgSO4x7H2O, 0.8 g of CaCl2x2H2O, 0.02 g of hemin, 0.2 g of p-aminobenzoic acid. Obtained mixture is autoclaved for 30 minutes at 134 °C and pressure of 2 atm, then 2.5 g of nicotinamide, 0.004 g of thiamine, 0.003 g of cysteine HCl are added⋅. If the unified intestinal medium is used for more than 72 hours, 1.5 g of the vitamin mixture containing per 1 l: 0.001 g of menadione, 0.002 g of D-biotin, 0.0005 g of vitamin B12, 0.01 g of pantothenic acid, 0.004 g of thiamine, 0.005 g of nicotinamide acid.
EFFECT: invention provides cultivation of the intestinal microbiota, which is not cultivated in standard intestinal media, and reproduction of the microbiota composition for a long time of cultivation.
1 cl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MODELING CHICKEN MICROBIOTA IN AN ARTIFICIAL CAECUM | 2021 |
|
RU2773094C1 |
SYNBIOTIC COMPOSITIONS | 2019 |
|
RU2799354C2 |
COMPOSITION OF THE ARTIFICIAL INTESTINAL MEDIUM FOR THE STUDY OF THE MICROBIOTA OF THE CAECUM OF CHICKEN | 2021 |
|
RU2772350C1 |
ANTIBACTERIAL AGENTS AND METHOD FOR TREATING INTESTINAL YERSINIOSIS OR PSEUDOTUBERCULOSIS, OR COLIBACILLOSIS | 2016 |
|
RU2614730C1 |
AGENT FOR REDUCTION OF INTESTINAL MICROBIOCENOSIS IN CASE OF DYSBIOSIS | 2015 |
|
RU2593584C1 |
NUTRIENT COMPOSITIONS WITH 2FL AND LNNT FOR USE IN INDUCING INTESTINAL MICROBIOTA, WHICH IS SIMILAR TO INTESTINAL MICROBIOTA OF INFANTS IN BREASTFEEDING | 2016 |
|
RU2724590C2 |
METHOD FOR PREVENTION OF DEVELOPING BACTERIAL INTESTINAL INFECTION | 2012 |
|
RU2526806C2 |
METHOD OF TREATING ALZHEIMER'S DISEASE THROUGH REGULATION OF INTESTINAL MICROORGANISMS | 2020 |
|
RU2810079C2 |
SYSTEM AND METHOD OF INTERPRETING DATA AND PROVIDING RECOMMENDATIONS TO USER BASED ON GENETIC DATA THEREOF AND DATA ON COMPOSITION OF INTESTINAL MICROBIOTA | 2017 |
|
RU2699284C2 |
COMPOSITION AND METHODS FOR MODULATING GUT MICROBIOTA IN CANINE | 2017 |
|
RU2742512C2 |
Authors
Dates
2025-02-11—Published
2023-12-13—Filed